ZynexZYXIQ Median PS Value is $8.92 as of Jul. 02, 2026, which is 487% above its 10-year median of 1.52. The stock has 5 warning signs investors should review.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Zynex's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2025 was $3.448. Zynex's 10-Year median PS Ratio is 2.587. Therefore, the Median PS Value for today is $8.92.
As of today (2026-07-02), Zynex's share price is $0.055. Zynex's Median PS Value is $8.92. Therefore, Zynex's Price to Median PS Value for today is 0.01.
The historical rank and industry rank for Zynex's Median PS Value or its related term are showing as below:
ZYXIQ'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.01 Med: 1.52 Max: 18.53
Current: 0.01
During the past 13 years, the highest Price to Median PS Value of Zynex was 18.53. The lowest was 0.01. And the median was 1.52.
ZYXIQ's Price-to-Median-PS-Value is not ranked
in the Medical Distribution industry.
Industry Median: 0.81
vs ZYXIQ: 0.01
Zynex (OTCPK:ZYXIQ) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Zynex's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.055
/
8.92
=
0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zynex Median PS Value Related Terms
Zynex Median PS Value Historical Data
* Premium members only.
The historical data trend for Zynex's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ZYXIQ vs MCK, COR, CAH: Median PS Value Comparison
For the Medical Distribution subindustry, Zynex's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zynex Price-to-Median-PS-Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Zynex's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Zynex's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 2.587.
Zynex's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.448.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zynex (ZYXIQ) has a Median PS Value of $8.92 as of Jul. 02, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Zynex and its competitors. This is 487% above median its historical median of 1.52. Over the past decade, Zynex's Median PS Value has ranged from 0.01 to 18.53.
Is Zynex's Median PS Value too high?
Zynex's current Median PS Value of $8.92 is 487% above median its 10-year median of 1.52. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 18.53. The Medical Distribution industry median Median PS Value is 0.81. Zynex's value of $8.92 is 1001.2% above this industry median.
How does Zynex's Median PS Value compare to MCK and COR?
Zynex's Median PS Value of $8.92 can be compared against companies in the Medical Distribution industry. The industry median Median PS Value is 0.81. Zynex's value of $8.92 is 1001.2% above this benchmark. Historically, Zynex's own Median PS Value has ranged from 0.01 to 18.53 over the past decade. While the company's 10-year median is 1.52 vs. the industry median of 0.81, Zynex has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Distribution company?
The median Median PS Value among Medical Distribution companies is 0.81, based on 70 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zynex's current Median PS Value of $8.92 is 1001.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Zynex and its competitors. For the Medical Distribution industry, the median Median PS Value is 0.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zynex's current Median PS Value is $8.92, which is 487% above median its own 10-year median of 1.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zynex stock overvalued right now?
Zynex (ZYXIQ) has a current Median PS Value of $8.92. The stock's GF Value™ is $5.54, compared to a current price of $0.06 — trading 99% below its estimated fair value. The current Median PS Value is $8.92, which is 487% above median its 10-year median of 1.52 and 1001.2% above the Medical Distribution industry median of 0.81. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Zynex (ZYXIQ), the current Median PS Value is $8.92 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ZYXIQ has been successfully added to your 